Pharmacogenetic Variation in Drug Oxidizing CYPs: Impact on Drug Therapy, Drug Safety and Drug Interactions

E-ISSN： 1875-6204|1|3|159-173

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.1, Iss.3, 2003-09, pp. : 159-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy

By Warrington Jill S Shaw Leslie M

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 487-503

Informa Healthcare

Access to resources Recommend Favorite

Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy: A Review

By Mann Michael W.

CNS Drugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 143-164

Adis International

Access to resources Recommend Favorite

Drug interactions

By Boobis Alan Watelet Jean-Baptiste Whomsley Rhys Benedetti Margherita Strolin Demoly Pascal Tipton Keith

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 486-527

Informa Healthcare

Access to resources Recommend Favorite

CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects

By Holstein Andreas Beil Winfried Kovacs Peter

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1549-1563

Informa Healthcare

Access to resources Recommend Favorite

The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety

By Copeland Robert A

Expert Opinion on Drug Discovery, Vol. 5, Iss. 4, 2010-04 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite